WO2000012048A3 - Carbapenem antibacterial compositions and methods of treatment - Google Patents
Carbapenem antibacterial compositions and methods of treatment Download PDFInfo
- Publication number
- WO2000012048A3 WO2000012048A3 PCT/US1999/020052 US9920052W WO0012048A3 WO 2000012048 A3 WO2000012048 A3 WO 2000012048A3 US 9920052 W US9920052 W US 9920052W WO 0012048 A3 WO0012048 A3 WO 0012048A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methicillin resistant
- combination
- antibacterial compositions
- treating
- useful
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU61335/99A AU6133599A (en) | 1998-09-01 | 1999-08-31 | Carbapenem antibacterial compositions and methods of treatment |
CA002341650A CA2341650A1 (en) | 1998-09-01 | 1999-08-31 | Carbapenem antibacterial compositions and methods of treatment |
EP99948094A EP1115419A2 (en) | 1998-09-01 | 1999-08-31 | Carbapenem antibacterial compositions and methods of treatment |
JP2000571020A JP2002525275A (en) | 1998-09-01 | 1999-08-31 | Carbapenem antimicrobial compositions and methods of treatment |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9873898P | 1998-09-01 | 1998-09-01 | |
US60/098,738 | 1998-09-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000012048A2 WO2000012048A2 (en) | 2000-03-09 |
WO2000012048A3 true WO2000012048A3 (en) | 2000-06-22 |
Family
ID=22270688
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/020052 WO2000012048A2 (en) | 1998-09-01 | 1999-08-31 | Carbapenem antibacterial compositions and methods of treatment |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1115419A2 (en) |
JP (1) | JP2002525275A (en) |
AU (1) | AU6133599A (en) |
CA (1) | CA2341650A1 (en) |
WO (1) | WO2000012048A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090018111A1 (en) * | 2004-10-08 | 2009-01-15 | Makoto Sunagawa | Novel Antimicrobial Medicament |
WO2008085913A1 (en) * | 2007-01-04 | 2008-07-17 | Rib-X Pharmaceuticals, Inc. | Methods for treating, preventing, or reducing the risk of opthalmic, otic, and nasal infections |
CA2743585C (en) * | 2008-11-12 | 2017-07-11 | Synedgen, Inc. | Chitosan derivatives alone or in combination for the treatment of mdr microbial infections |
US20140348915A9 (en) * | 2012-08-22 | 2014-11-27 | Xenoport, Inc. | Oral Dosage Forms of Methyl Hydrogen Fumarate and Prodrugs Thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5494666A (en) * | 1994-03-11 | 1996-02-27 | Hoffmann-La Roche Inc. | β-lactam compounds |
US5637579A (en) * | 1993-08-24 | 1997-06-10 | Hoffmann-La Roche Inc. | Penam derivatives |
-
1999
- 1999-08-31 WO PCT/US1999/020052 patent/WO2000012048A2/en not_active Application Discontinuation
- 1999-08-31 CA CA002341650A patent/CA2341650A1/en not_active Abandoned
- 1999-08-31 AU AU61335/99A patent/AU6133599A/en not_active Abandoned
- 1999-08-31 EP EP99948094A patent/EP1115419A2/en not_active Withdrawn
- 1999-08-31 JP JP2000571020A patent/JP2002525275A/en not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5637579A (en) * | 1993-08-24 | 1997-06-10 | Hoffmann-La Roche Inc. | Penam derivatives |
US5494666A (en) * | 1994-03-11 | 1996-02-27 | Hoffmann-La Roche Inc. | β-lactam compounds |
Also Published As
Publication number | Publication date |
---|---|
EP1115419A2 (en) | 2001-07-18 |
CA2341650A1 (en) | 2000-03-09 |
WO2000012048A2 (en) | 2000-03-09 |
AU6133599A (en) | 2000-03-21 |
JP2002525275A (en) | 2002-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lee et al. | Blood stream infections in patients in the burn intensive care unit | |
WO2002072600A3 (en) | Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections | |
WO2003037259A3 (en) | Methods for the prevention or treatment of bacterial and fungal infections | |
EP1037650A4 (en) | Methods and compositions for the treatment and prevention of staphylococcus aureus infections | |
HK1074620A1 (en) | Process for the preparation of vinyl-pyrrolidinonecephalosporine derivatives | |
RU2019136978A (en) | ANTIBACTERIAL COMPOSITION AND METHOD FOR TREATING STaphylococcal Infections ANTIBACTERIAL COMPOSITION | |
WO2000012048A3 (en) | Carbapenem antibacterial compositions and methods of treatment | |
WO2005054234A3 (en) | Substituted piperidino phenyloxazolidinones having antimicriobial activity with improved in vivo efficacy | |
WO2001056554A3 (en) | Use of retinoid-type compounds as antibacterial agents | |
ATE449775T1 (en) | CARBACEPHEM BETA-LACTAM ANTIBIOTICS | |
DE60039992D1 (en) | EYE-ONLY CONTAINING VANCOMYCINHYDROCHLORIDE FOR THE TREATMENT OF INFECTIOUS EYE DISEASES | |
EP1028962A4 (en) | Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment | |
WO2004007489A3 (en) | Antibacterial substituted cyanomethyl (ene) piperidinophenyl oxazolidinones, process or their preparation, and pharmaceutical compositions containing them | |
DE60030300D1 (en) | TOPICAL TREATMENT FOR PREVENTING EYE INFECTIONS | |
NZ332453A (en) | (1R,5S,6S)-6-[(1R)-1-hydroxyethyl]-1-methyl-2-[(2S,4S)-2-[(3R)-3-methylaminomethylpyrrolidin-1-ylcarbonyl]pyrrolidin-4-ylthio]-1-carbapen-2-em-3-carboxylic acid for the prevention or treatment of bacterial infections | |
MX2021012375A (en) | Method of treating and preventing bone and joint infections. | |
WO2020232471A3 (en) | Methods and compositions comprising staphylococcus protein a (spa) variants | |
WO2004014316A3 (en) | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases | |
CY1108472T1 (en) | METHOD FOR TREATMENT OF BACTERIAL INFECTIONS USING GEMIFLOXACINE OR A SALT AND ANTI-BACTERIAL AGENT CARBAPENEMIS | |
WO2001063539A8 (en) | Anti-infective agents useful against multidrug-resistant strains of bacteria | |
Eom et al. | Antibiotic treatment of methicillin-resistant Staphylococcus epidermidis (MRSE) infection | |
WO2004014317A3 (en) | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases | |
WO2021048613A3 (en) | Penam derivatives for treating bacterial infections | |
DK0897725T3 (en) | Therapy against Staphylococcus aureus | |
WO2003068791A3 (en) | Macrolides with activity against methicillin-resistant staphylococcus aureus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
ENP | Entry into the national phase |
Ref document number: 2341650 Country of ref document: CA Ref country code: CA Ref document number: 2341650 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 61335/99 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2000 571020 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999948094 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1999948094 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999948094 Country of ref document: EP |